SIGA
SIGA Technologies, Inc.
$3.44
-0.12
(-3.37%)
Mkt Cap
246.73M
Volume
324,085
52W Range
3.41-9.62
Sector
Healthcare
Beta
0.89
EPS (TTM)
0.29
P/E Ratio
12.01
Revenue (TTM)
93.78M
Rev Growth (5Y)
-5.4%
EPS Growth (5Y)
-14.2%
AlphaVal · Fair Value
What we estimate one share is worth
$22.14
Undervalued
strong signal
84.5% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Platform & Compounding FCF
64.8 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.
Company Description
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 94.60M | 138.72M | 139.92M | 110.78M | 133.67M | 124.96M | 26.74M | 477.05M | 12.27M | 14.99M | 8.18M | 3.14M |
| Net Income | 23.30M | 59.21M | 68.07M | 33.90M | 69.45M | 56.34M | (7.24M) | 421.81M | (36.24M) | (39.70M) | (39.45M) | (265.46M) |
| EPS | 0.33 | 0.83 | 0.95 | 0.46 | 0.92 | 0.71 | -0.09 | 5.28 | -0.46 | -0.69 | -0.73 | -4.97 |
| Free Cash Flow | 43.12M | 48.72M | 94.78M | 41.61M | 11.44M | 71.50M | (18.23M) | 68.77M | (8.26M) | (115.61M) | 11.00M | 14.15M |
| FCF / Share | 0.60 | 0.68 | 1.33 | 0.57 | 0.15 | 0.90 | -0.23 | 0.86 | -0.10 | -2.02 | 0.20 | 0.26 |
| Operating CF | 43.47M | 48.76M | 94.80M | 41.61M | 11.49M | 71.52M | (18.20M) | 68.87M | (8.16M) | (115.59M) | 11.11M | 14.18M |
| Total Assets | 219.47M | 244.34M | 254.35M | 195.04M | 214.73M | 149.83M | 198.57M | 203.44M | 144.67M | 160.98M | 185.73M | 166.39M |
| Total Debt | 595,169 | 546,820 | 564,009 | 528,170 | 466,830 | 449,940 | 80.46M | 75.55M | 71.05M | 66.55M | 0 | 1.99M |
| Cash & Equiv | 154.97M | 155.40M | 150.15M | 98.79M | 103.14M | 117.89M | 65.25M | 100.65M | 19.86M | 28.70M | 112.71M | 99.71M |
| Book Value | 198.82M | 215.80M | 196.86M | 170.16M | 174.31M | 129.79M | 97.78M | 102.91M | (323.14M) | (287.42M) | (284.43M) | (246.50M) |
| Return on Equity | 0.12 | 0.27 | 0.35 | 0.20 | 0.40 | 0.43 | -0.07 | 4.10 | N/A | N/A | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.24M | 3.80M | 2.62M | 81.12M | 7.04M | 81.47M | 10.01M | 21.81M | 25.43M | 116.48M | 9.24M | 5.88M |
| Net Income | (3.45M) | (5.40M) | (6.37M) | 35.48M | (408,223) | 45.76M | 1.34M | 1.83M | 10.28M | 72.26M | (393,066) | (2.88M) |
| EPS | -0.05 | -0.08 | -0.09 | 0.50 | -0.01 | 0.64 | 0.02 | 0.03 | 0.14 | 1.02 | -0.01 | -0.04 |
| Free Cash Flow | (8.66M) | (16.90M) | (10.10M) | 63.08M | 7.04M | 56.29M | (7.41M) | 5.95M | (6.12M) | 79.03M | (5.10M) | (3.60M) |
| FCF / Share | -0.12 | -0.24 | -0.14 | 0.88 | 0.10 | 0.79 | -0.10 | 0.08 | -0.09 | 1.11 | -0.07 | -0.05 |
| Operating CF | (8.66M) | (16.86M) | (9.81M) | 63.08M | 7.06M | 56.31M | (7.38M) | 5.95M | (6.12M) | 79.03M | (5.10M) | (3.58M) |
| Total Assets | 219.39M | 219.47M | 231.60M | 235.33M | 247.07M | 244.34M | 195.35M | 192.66M | 243.15M | 254.35M | 158.38M | 146.51M |
| Total Debt | 638,231 | 595,169 | 914,548 | 570,426 | 558,651 | 546,820 | 535,234 | 523,889 | 503,470 | 564,009 | 554,732 | 545,558 |
| Cash & Equiv | 145.56M | 154.97M | 171.96M | 182.46M | 162.27M | 155.40M | 99.27M | 106.95M | 143.87M | 150.15M | 71.11M | 76.21M |
| Book Value | 151.62M | 198.82M | 203.48M | 209.31M | 216.13M | 215.80M | 169.44M | 167.56M | 164.99M | 196.86M | 124.14M | 124.07M |
| Return on Equity | -0.02 | -0.03 | -0.03 | 0.17 | -0.00 | 0.21 | 0.01 | 0.01 | 0.06 | 0.37 | -0.00 | -0.02 |
SIGA News
Siga Technologies Q1 Earnings Call Highlights
SIGA Technologies, Inc. (SIGA) Q1 2026 Earnings Call Transcript
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
JPMorgan Chase & Co. Increases Stake in Siga Technologies Inc. $SIGA
Siga Technologies Sees Unusually High Options Volume (NASDAQ:SIGA)
Siga Technologies (NASDAQ:SIGA) and CASI Pharmaceuticals (NASDAQ:CASI) Financial Comparison
Why Are Siga Technologies Shares Trading Higher?
SIGA Declares Special Cash Dividend of $0.60 Per Share
EOM Pharmaceutical (OTCMKTS:IMUC) & Siga Technologies (NASDAQ:SIGA) Financial Survey